Treatment of Pilonidal Sinus Disease Using Surgiflo as a Sealant: A New Concept

Mansoura University

Status: Completed

Conditions: Pilonidal Sinus Disorder

Treatments: Procedure: Surgiflo injection

Study type: Interventional

Funder types: Other

Identifiers

NCT02638064

mansourau25

Details and patient eligibility

About

Assessment of surgiflo injection for treating pilonidal sinus disease

Full description

Evaluation of injection of Surgiflo as a sealent in treatment of pilonidal sinus, evaluation includes recurrence, infection, complications and patient satisfaction over 2 years of follow up

Enrollment: 50 patients

Sex: All

Ages: 14 to 45 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Patients included in the study had simple midline PS with single or multiple tracts and no lateral extensions. Recurrent cases of PS after previous surgery were also included in the study

Exclusion criteria

We excluded from the study patients with severe scarring at the natal cleft due to previous surgery or infection and patients with signs of an acute abscess.

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

50 participants in 1 patient group

Surgiflo injection

Experimental group

Description:

Injection of surgiflo in the pilonidal sinus cavity after curettage of its content

Treatment:

Procedure: Surgiflo injection